The Journal

Our net exposure to markets in the portfolio is often seen as a guide to how we feel about the world, though one must be careful not to confuse a net exposure of 86% in the PWP - International Fund, as indicative of unbridled optimism (95% long, 9% short as at 27 May 2020).

The global healthcare sector has undergone significant change over the past 20 years with more to come, largely driven by advances in the dynamic biotech sector. Involved in such things as antibody therapies, protein engineering, gene editing, immunology and diagnostic tools, the biotech...

Automakers are likely to be among the businesses most acutely impacted by COVID-19. Over the next 12 months, most will likely rack up multi-billion-dollar losses that we will read about on the front pages of the financial press. However, accounting losses only tell half the story. Chief...

We are aware that there is a fake site impersonating Platinum’s website at "platinumasset.net" and we are in the process of having it taken down.

If anyone has entered their details into this...

Moderna is a US biotech company that the PWP - International Fund has owned since its IPO in late 2018 (bought at US$23), adding more in a placement early this year (at US$19).  Last night, the company announced positive data on its phase one trials for its vaccine (MRNA-1273) for the...

Most fast-moving consumer goods (FMCG) companies are reporting unprecedented growth in sales and earnings as their product categories benefit from coronavirus-driven demand. One thing we are watching with interest is what the companies are saying about consumer behaviour during lockdowns, and...